Heart Pumps Market Size, Share, Forecast Report, 2026-2035

Heart Pumps Market Size, Growth and Trends 2026 to 2035

The global heart pumps market size was valued at USD 3.79 billion in 2025 and is expected to hit around USD 20.70 billion by 2035 with a CAGR of 18.5% from 2026 to 2035.

Heart Pumps Market Outlook

• Market Growth Overview: The heart pumps market is expected to grow significantly between 2026 and 2035, driven by rising cardiovascular disease prevalence, technological advancements, increased healthcare infrastructures, and improved clinical outcomes. 
• Sustainability Trends: Sustainability trends involve energy efficiency and portability, smart technology and AI integration, and ESG and manufacturing sustainability. 
• Major Investors: Major investors in the market include Abbot Laboratories, Johnson & Johnson, Medtronic plc, and Getting AB. 

Heart Pumps Market Report Scope

Heart Pumps Market Segment Insights

By Product Insights

How did the Ventricular Assist Devices Segment Dominate the Heart Pumps Market?

The ventricular assist devices segment is driven by engineering smaller, magnetically levitated pumps that drastically reduce complications, such as thrombosis and stroke. These technological leaps have transitioned VADs from temporary bridges to transplant to viable, permanent destination therapies for patients ineligible for surgery. The shift toward more durable, high-efficiency devices is expanding the patient pool and solidifying VADs as the gold standard for mechanical circulatory support.

How did the Total Artificial Hearts Segment Expect to Hold the Fastest-Growing Heart Pumps Market in the Coming Years?

The total artificial hearts segment is driven by the next-generation total artificial hearts, which are enhancing patient mobility through wireless power, AI-enabled self-regulation, and smaller designs suitable for a broader range of patients. These innovations, combined with increased use in destination therapy and rapid growth in the Asia-Pacific, are transforming heart failure treatment. With the regulatory approvals for companies like BiVACOR, the market is expanding as a sustainable long-term solution.   

By Flow Regime Insights

How did the Centrifugal Flow Pumps Segment Account for the Largest Share in the Heart Pumps Market?

The centrifugal flow pumps segment is driven by the rapid transition to magnetically levitated centrifugal pumps, which have set a new clinical standard by drastically reducing blood trauma and mechanical wear. As the gold standard for end-stage heart failure, these devices, led by LVADs, are meeting the urgent demand from an aging global population with rising cardiovascular disease. Their ability to provide high-volume, continuous blood flow makes them indispensable for both critical care and long-term destination therapy. 

How did the Magnetic Levitation Flow Segment Expect to Hold the Fastest-Growing Heart Pumps Market in the Coming Years?

The magnetic levitation flow segment is driven by a shift towards third-generation MagLev pumps, which eliminate mechanical friction to achieve superior long-term survival rates and a two-year success rate. By integrating artificial pulse features and miniaturised designs, these devices mimic natural blood flow while enabling less invasive surgical procedures and faster recovery. This shift toward bearingless technology has transformed heart pumps from temporary bridges into reliable, permanent destination therapies for end-stage heart failure.

By Therapy Insights

How did the Bridge-to-Transplant Segment Account for the Notable Share in the Heart Pumps Market?

The bridge-to-transplant segment is driven by the transition from experimental to standard-of-care BTT solutions, which is turning mechanical circulatory support into the primary bridge for end-stage heart failure management. Enhanced clinical awareness and the expansion of specialized transplant programs are further accelerating the adoption of these life-saving devices. The technological breakthroughs in continuous-flow LVADs have drastically improved survival rates and quality of life for patients on transplant waiting lists.

How did the Destination Therapy Segment Expect to Hold the Fastest-Growing Heart Pumps Market in the Coming Years?

The destination therapy segment is driven by engineering miniaturized, durable continuous-flow VADs; these firms have slashed complication rates, making long-term mechanical support a safe, permanent alternative to transplantation. The favourable reimbursement policies in the U.S. and Japan have expanded access to life-extending technology for older patients. The transition from temporary bridge to permanent destination support is turning heart pumps into the primary standard of care for end-stage heart failure.

By Location Insights

How did the Implantable Heart Pump Segment Account for the Notable Share in the Heart Pumps Market?

The implantable heart pump segment is driven by the technological shifts toward magnetically levitated (MagLev) continuous-flow pumps, which have revolutionized the sector by eliminating friction, which significantly reduces the risk of thrombosis and strokes while increasing device durability. These innovations have established implantable devices as the primary alternative to transplantation, serving as a critical bridge-to-transplant (BTT) and an increasingly popular destination therapy (DT) for patients ineligible for surgery.

How did the Extracorporeal Heart Pump Devices Segment Expect to Hold the Fastest-Growing Heart Pumps Market in the Coming Years?

The extracorporeal heart pump devices segment is driven by the start-up and medtech economy, which is accelerating the extracorporeal heart pump segment by engineering compact, portable ECMO systems that enhance usability in critical care. The technological leap has made extracorporeal support a vital bridge-to-transplant for both pediatric and adult patients facing acute organ shortages. The shift toward integrated, high-efficiency portable units is transforming intensive care and neonatal support into a high-growth, life-saving market.

By End User Insights

How did the Hospitals Segment Account for the Notable Share in the Heart Pumps Market?

The hospitals segment is driven by integrating advanced ICUs and 24/7 monitoring. Hospitals effectively manage the complex post-operative complications, such as thrombosis and infection, that define end-stage heart failure care. The favorable reimbursement policies in developed regions support the high costs of infrastructure-heavy procedures like ECMO and Bridge-to-Transplant. The global burden of heart failure rises, and hospitals remain the primary hubs for delivering life-saving, continuous-flow technology to the most critical patient populations.

How did the Ambulatory Surgical Centers Segment Expect to Hold the Fastest-Growing Heart Pumps Market in the Coming Years?

The ambulatory surgical center segment is driven by these centres provide a cost-effective, efficient alternative to traditional hospitals, attracting both payers and patients through reduced recovery times. By investing in specialty-specific infrastructure, ASCs are successfully expanding their capacity to manage complex cardiac conditions outside of major medical hubs. This move toward minimally invasive, outpatient support is decentralising advanced heart failure care and driving a new wave of accessible cardiovascular services.

Key Players in the Heart Pumps Market

• Calon Cardio-Technology Ltd. is developing the MiniVAD™, a next-generation miniaturized ventricular assist device (VAD) designed for long-term implantation in patients with advanced chronic heart failure. 
• Jarvik Heart, Inc. develops and manufactures the Jarvik 2000, a small, axial-flow ventricular assist device that can be implanted without a pump pocket, allowing for both bridging to transplantation and long-term, destination therapy. 
• Berlin Heart GmbH specializes in developing ventricular assist devices (VADs) for both children and adults, holding a unique position as the only company providing such technology for infants and small children. 
• Abiomed (Johnson & Johnson MedTech) is a dominant leader in the heart pump market, offering the Impella platform, which are temporary, catheter-based, percutaneous heart pumps that provide circulatory support. 

Global Heart Pumps Market Segmentation

By Product

• Intra-aortic Balloon Pumps
• Ventricular Assist Devices
  • Left Ventricle Assist Devices (LVAD)
  • Right Ventricle Assist Devices (RVAD)
  • Biventricular Assist Devices (BVAD)
  • Others
• Total Artificial Heart

By Flow Regime

• Centrifugal Flow Pump (CFP)
• Axial Flow Pump (AFP)
• Mixed Flow Pump (MFP)

By Therapy

• Bridge-to-Candidacy (BTC)
• Bridge-to-Transplant (BTT)
• Destination Therapy (DT)
• Other Therapies

By Location

• Implantable Heart Pump Devices
• Extracorporeal Heart Pump Devices

By End User

• Hospitals
• Ambulatory Surgical Centers
• Specialty Clinics
• Others

Regional Analysis and Forecast

Further, this research study analyses market size, production, consumption and its advancement trends at global, regional, and country level for period 2026 to 2035 and covers following region in its scope:

• North America
  • United States
  • Canada
• Europe
  • Germany
  • United Kingdom
  • Italy
  • France
  • Rest of EU
• Asia Pacific
  • China
  • India
  • Japan
  • Southeast Asia
  • Rest of APAC
• Central & South America
  • Brazil
  • Argentina
  • Rest of Central & South America
• Middle East and Africa
  • UAE
  • Saudi Arabia
  • Rest of MEA